MetLife Investment Management’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.7M Buy
106,524
+81,952
+334% +$18.2M 0.14% 112
2025
Q4
$3.98M Buy
24,572
+213
+0.9% +$37K 0.02% 732
2025
Q3
$3.67M Buy
24,359
+703
+3% +$93.8K 0.02% 775
2025
Q2
$3.04M Buy
23,656
+1,636
+7% +$159K 0.02% 792
2025
Q1
$1.59M Sell
22,020
-49
-0.2% -$5.22K 0.01% 1143
2024
Q4
$2.51M Sell
22,069
-502
-2% -$59.6K 0.01% 927
2024
Q3
$2.25M Sell
22,571
-443
-2% -$36.7K 0.01% 958
2024
Q2
$1.99M Buy
23,014
+15,284
+198% +$1.39M 0.01% 973
2024
Q1
$631K Buy
7,730
+19
+0.2% +$1.19K ﹤0.01% 1554
2023
Q4
$370K Sell
7,711
-140
-2% -$5.96K ﹤0.01% 1859
2023
Q3
$292K Buy
7,851
+468
+6% +$15.4K ﹤0.01% 1977
2023
Q2
$183K Sell
7,383
-816
-10% -$14K ﹤0.01% 2335
2023
Q1
$117K Buy
8,199
+18
+0.2% +$264 ﹤0.01% 2485
2022
Q4
$112K Sell
8,181
-51
-0.6% -$680 ﹤0.01% 2548
2022
Q3
$80K Sell
8,232
-125
-1% -$1.4K ﹤0.01% 2725
2022
Q2
$68.7K Sell
8,357
-12,435
-60% -$141K ﹤0.01% 2782
2022
Q1
$291K Buy
+20,792
New +$370K ﹤0.01% 2113

Other funds holding VRT

MetLife Investment Management's VRT Position: Q1 2026 in Review

MetLife Investment Management increased its Vertiv (VRT) stake by 334% in Q1 2026, buying an estimated $18.2M and bringing the position to 106,524 shares worth $26.7M. The position accounts for 0.14% of the portfolio, ranked #112.

MetLife Investment Management first reported a position in VRT in Q1 2022 and has held it in 17 quarters since. 1,824 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • MetLife Investment Management held 106,524 shares of Vertiv worth $26.7M as of Q1 2026.
  • MetLife Investment Management bought 81,952 Vertiv shares in Q1 2026, an estimated $18.2M.
  • Vertiv made up 0.14% of MetLife Investment Management's portfolio in Q1 2026, its #112 holding.
  • MetLife Investment Management first reported a position in Vertiv in Q1 2022 and has held it in 17 quarters since.
  • 1,824 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.